 |
|
|
| |
Thigh Injections of Cabotegravir + Rilpivirine in Virally Suppressed Adults With HIV-1
|
| |
| |
CROI February 19-22, 2023; Virtual and Seattle, WA
Franco Felizarta1, Ronald D’Amico2, Kehui Wang3, Herta Crauwels4, Mar Masia5, Miguel Garcia Deltoro6, Olaf Degen7, Jonathan Angel8, Chiu-Bin Hsiao9, Vasiliki Chounta2, Kelong Han3, Conn Harrington2, Kelly Rimler3, William R. Spreen2, Susan L. Ford10
1Private Practice, Bakersfield, California, United States; 2ViiV Healthcare, Durham, NC, United States; 3GSK, Collegeville, PA, United States; 4Janssen Research & Development, Beerse, Belgium; 5Hospital General Universitario de Elche, Alicante, Spain; 6Consorcio Hospital General Universitario de Valencia, Valencia, Spain; 7University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 8University of Ottawa, Ottawa, ON, Canada; 9Medicine Institute, School of Medicine, Infectious Diseases, Drexel University, Positive Health Clinic, Allegheny General Hospital, Allegheny Health Network, Pittsburgh, PA, United States; 10GSK, Durham, NC, United States
|
| |
|
|
|
|
|
